Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its ...

Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) have both announced recent regulatory milestones for liquid embolic ...

Though the Medtronic OmniaSecure is the world's smallest defibrillation lead, the product development story isn't one of ...

Hugo is about to joust da Vinci. It’s not a battle between Renaissance geniuses. Instead, a commercial fight is brewing between massive medtech companies to control the future of the ...

Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned ...

Salmon retired from Medtronic in September after a more than 20-year tenure at the medtech giant. Most recently, Salmon ...

Avenu's Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic's Commitment to Improving Outcomes for Patients with ...

Medtronic is a healthcare behemoth, developing and manufacturing medical devices for chronic diseases, with a broad and dominant portfolio of industry-leading products. The company has increased its ...

Medtronic Inc. has agreed to acquire Restore Medical Inc. for $29 million, a deal that rescues the cash-starved company from possible insolvency. The medical-device giant will pay $1.60 per Restore ...

Medtronic (MDT) has quietly outperformed the broader healthcare space over the past year, and that steady climb is getting investors to revisit whether this long standing medical device leader still ...

It has been about a month since the last earnings report for Medtronic (MDT). Shares have lost about 2% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the ...

Medtronic plans to acquire a small medical device company that treats kidney disease with a minimally invasive interventional treatment. Medtronic, which is based in Ireland but managed out of Fridley ...